245 related articles for article (PubMed ID: 15609422)
1. New drugs for rheumatoid arthritis.
Kalil AC
N Engl J Med; 2004 Dec; 351(25):2659-61; author reply 2659-61. PubMed ID: 15609422
[No Abstract] [Full Text] [Related]
2. New drugs for rheumatoid arthritis.
Roberts LJ
N Engl J Med; 2004 Dec; 351(25):2659-61; author reply 2659-61. PubMed ID: 15602032
[No Abstract] [Full Text] [Related]
3. New drugs for rheumatoid arthritis.
Messori A; Santarlasci B; Vaiani M
N Engl J Med; 2004 Aug; 351(9):937-8. PubMed ID: 15329436
[No Abstract] [Full Text] [Related]
4. Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?
Garcia-Porrua C; Gonzalez-Gay MA; Quevedo V
J Rheumatol; 2006 Feb; 33(2):433; author reply 433-4. PubMed ID: 16465676
[No Abstract] [Full Text] [Related]
5. Strengths and limitations of a systematic review on DMARDs for rheumatoid arthritis.
Smolen JS; Aletaha D
Nat Clin Pract Rheumatol; 2008 Jun; 4(6):296-7. PubMed ID: 18461061
[No Abstract] [Full Text] [Related]
6. BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.
Bukhari M; Abernethy R; Deighton C; Ding T; Hyrich K; Lunt M; Luqmani R; Kiely P; Bosworth A; Ledingham J; Ostör A; Gadsby K; McKenna F; Finney D; Dixey J;
Rheumatology (Oxford); 2011 Dec; 50(12):2311-3. PubMed ID: 21546351
[No Abstract] [Full Text] [Related]
7. Biologic therapy for early rheumatoid arthritis: the latest evidence.
Castro-Rueda H; Kavanaugh A
Curr Opin Rheumatol; 2008 May; 20(3):314-9. PubMed ID: 18388524
[TBL] [Abstract][Full Text] [Related]
8. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E
Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489
[TBL] [Abstract][Full Text] [Related]
9. [Three joints swollen, blood sedimentation increased. Methotrexate to be given immediately?].
Burmester GR
MMW Fortschr Med; 2004 Sep; 146(37):10. PubMed ID: 15887693
[No Abstract] [Full Text] [Related]
10. [So that the patients.would be able to move for a long time after first diagnosis of rheumatism. Approach as an emergency!].
Fath R
MMW Fortschr Med; 2004 Sep; 146(37):4-5. PubMed ID: 15887690
[No Abstract] [Full Text] [Related]
11. Do all drugs and treatments for rheumatoid arthritis have the same efficacy?
Weisman MH
Nat Clin Pract Rheumatol; 2008 Jun; 4(6):298-9. PubMed ID: 18431369
[No Abstract] [Full Text] [Related]
12. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
13. Immunization of patients with rheumatoid arthritis with antitumor necrosis factor alpha therapy and methotrexate.
Brezinschek HP; Hofstaetter T; Leeb BF; Haindl P; Graninger WB
Curr Opin Rheumatol; 2008 May; 20(3):295-9. PubMed ID: 18388521
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
[TBL] [Abstract][Full Text] [Related]
15. [Basic therapeutic and immunosuppressive drugs in rheumatoid arthritis. No fear of "heavy weapons"].
Krüger K
MMW Fortschr Med; 2002 Aug; 144(33-34):25-30. PubMed ID: 12380140
[No Abstract] [Full Text] [Related]
16. Cutaneous mucormycosis complicating methotrexate, prednisone, and infliximab therapy.
Gadadhar H; Hawkins S; Huffstutter JE; Panda M
J Clin Rheumatol; 2007 Dec; 13(6):361-2. PubMed ID: 18176152
[No Abstract] [Full Text] [Related]
17. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
Fautrel B; Guillemin F; Meyer O; de Bandt M; Berthelot JM; Flipo RM; Lioté F; Maillefert JF; Wendling D; Saraux A; Combe B; Le Loët X; ; ;
Arthritis Rheum; 2009 Apr; 61(4):425-34. PubMed ID: 19333993
[TBL] [Abstract][Full Text] [Related]
18. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
[No Abstract] [Full Text] [Related]
19. Add-on or step-up trials for new drug development in rheumatoid arthritis: a new standard?
Boers M
Arthritis Rheum; 2003 Jun; 48(6):1481-3. PubMed ID: 12794813
[No Abstract] [Full Text] [Related]
20. Rituximab for the treatment of rheumatoid arthritis.
Schuna AA
Pharmacotherapy; 2007 Dec; 27(12):1702-10. PubMed ID: 18041890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
